These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11751692)

  • 1. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
    Chiba-Falek O; Nussbaum RL
    Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
    Chiba-Falek O; Kowalak JA; Smulson ME; Nussbaum RL
    Am J Hum Genet; 2005 Mar; 76(3):478-92. PubMed ID: 15672325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene.
    Chiba-Falek O; Touchman JW; Nussbaum RL
    Hum Genet; 2003 Oct; 113(5):426-31. PubMed ID: 12923682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD; Maraganore DM; Silburn PA
    Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein and heroin craving in opiate-dependent patients on injectable heroin maintenance.
    Dürsteler-MacFarland KM; Brugger I; Bönsch D; Schmid O; Kornhuber J; Bleich S; Wiesbeck GA
    Addict Biol; 2012 Sep; 17(5):875-86. PubMed ID: 21309955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy.
    Spadafora P; Annesi G; Pasqua AA; Serra P; Cirò Candiano IC; Carrideo S; Tarantino P; Civitelli D; De Marco EV; Nicoletti G; Annesi F; Quattrone A
    Neurosci Lett; 2003 Nov; 351(2):75-8. PubMed ID: 14583385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability.
    Tan EK; Tan C; Shen H; Chai A; Lum SY; Teoh ML; Yih Y; Wong MC; Zhao Y
    Neurosci Lett; 2003 Jan; 336(1):70-2. PubMed ID: 12493604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
    Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
    Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.
    Krüger R; Vieira-Saecker AM; Kuhn W; Berg D; Müller T; Kühnl N; Fuchs GA; Storch A; Hungs M; Woitalla D; Przuntek H; Epplen JT; Schöls L; Riess O
    Ann Neurol; 1999 May; 45(5):611-7. PubMed ID: 10319883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening.
    Dansithong W; Paul S; Scoles DR; Pulst SM; Huynh DP
    PLoS One; 2015; 10(8):e0136930. PubMed ID: 26317803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan.
    Izumi Y; Morino H; Oda M; Maruyama H; Udaka F; Kameyama M; Nakamura S; Kawakami H
    Neurosci Lett; 2001 Mar; 300(2):125-7. PubMed ID: 11207390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
    JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence.
    Bönsch D; Lederer T; Reulbach U; Hothorn T; Kornhuber J; Bleich S
    Hum Mol Genet; 2005 Apr; 14(7):967-71. PubMed ID: 15731118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease.
    Parsian A; Racette B; Zhang ZH; Chakraverty S; Rundle M; Goate A; Perlmutter JS
    Neurology; 1998 Dec; 51(6):1757-9. PubMed ID: 9855543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential tremor is not associated with alpha-synuclein gene haplotypes.
    Pigullo S; Di Maria E; Marchese R; Bellone E; Gulli R; Scaglione C; Battaglia S; Barone P; Martinelli P; Abbruzzese G; Ajmar F; Mandich P
    Mov Disord; 2003 Jul; 18(7):823-6. PubMed ID: 12815663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease.
    Tan EK; Chai A; Teo YY; Zhao Y; Tan C; Shen H; Chandran VR; Teoh ML; Yih Y; Pavanni R; Wong MC; Puvan K; Lo YL; Yap E
    Neurology; 2004 Jan; 62(1):128-31. PubMed ID: 14718715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease.
    Holzmann C; Krüger R; Saecker AM; Schmitt I; Schöls L; Berger K; Riess O
    J Neural Transm (Vienna); 2003 Jan; 110(1):67-76. PubMed ID: 12541013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element.
    Touchman JW; Dehejia A; Chiba-Falek O; Cabin DE; Schwartz JR; Orrison BM; Polymeropoulos MH; Nussbaum RL
    Genome Res; 2001 Jan; 11(1):78-86. PubMed ID: 11156617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNCA REP1 and Parkinson's disease.
    Shu L; Zhang Y; Sun Q; Pan H; Guo J; Tang B
    Neurosci Lett; 2018 Aug; 682():79-84. PubMed ID: 29859327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.